Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer
Clinical trial NCT04837209 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04837209
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-21
- Primary completion
- 2027-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.